GlassScriptPhysician profile
Misty Lynn Mueller
NPI 1245914076
$3,574.85
in general payments reported to CMS, 2019-2025
23 companies · $1,593 in 2025
The $1,593 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $447 · 2024: $1,535 · 2025: $1,593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,574.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $575.79 | 2024-2025 | Slynd, Twirla |
| Novo Nordisk INC | $501.84 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Medtronic, INC. | $443.32 | 2024-2025 | Truclear, Ligasure |
| Biogen, INC. | $345.21 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $280.74 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $224.27 | 2024-2025 | |
| Mayne Pharma Commercial LLC | $203.80 | 2023-2025 | |
| Millicent US INC | $170.63 | 2023-2025 | Femlyv, Intrarosa |
| Myriad Women'S Health, INC. | $167.26 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $139.00 | 2024-2025 | Myosure Tissue Removal Device, Aptima, Thinprep 2000 Processor |
| Evofem Biosciences, INC. | $125.64 | 2024-2025 | Solosec, Phexx, Phexxi |
| Becton, Dickinson and Company | $85.49 | 2024 | Arista Ah Flexitip |
| Sumitomo Pharma America, INC. | $84.66 | 2024-2025 | Myfembree, Gemtesa |
| Organon LLC | $49.36 | 2024 | |
| Coloplast Corp | $30.05 | 2023 | Altis |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $26.62 | 2025 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $26.60 | 2023 | Balcoltra |
| Abbvie INC. | $21.58 | 2025 | |
| Coopersurgical, INC. | $17.40 | 2024 | Paragard T 380a |
| Avanos Medical | $15.60 | 2025 | On-Q Pump and Accessories |
| Lsi Solutions INC | $13.89 | 2025 | Fornisee |
| Lilly USA, LLC | $13.83 | 2025 | Zepbound |
| Aspira Women'S Health INC | $12.27 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Misty Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.